Immunomodulatory role of histamine H4 receptor in breast cancer

BACKGROUND: Although the role of histamine H4 receptor (H4R) in immune cells is being extensively investigated, its immunomodulatory function in cancer is completely unknown. This study aimed to investigate the role of H4R in antitumour immunity in a model of triple-negative breast cancer. METHODS: We evaluated growth parameters, histological characteristics and the composition of tumour, splenic and tumour draining lymph node (TDLN) immune subsets, in a syngeneic model, developed orthotopically with 4T1 cells in H4R knockout (H4R-KO) and wild-type mice. RESULTS: Mice lacking H4R show reduced tumour size and weight, decreased number of lung metastases and percentage of CD4+ tumour-infiltrating T cells, while exhibiting increased infiltration of NK cells and CD19+ lymphocytes. Likewise, TDLN of H4R-KO mice show decreased CD4+ T cells and T regulatory cells (CD4+CD25+FoxP3+), and increased percentages of NK cells. Finally, H4R-deficient mice show decreased Tregs in spleens and non-draining lymph nodes, and a negative correlation between tumour weight and the percentages of CD4+, CD19+ and NK splenic cells, suggesting that H4R also regulates antitumour immunity at a systemic level. CONCLUSIONS: This is the first report that demonstrates the participation of H4R in antitumour immunity, suggesting that H4R could be a target for cancer treatment.

Saved in:
Bibliographic Details
Main Authors: Sterle, Helena A., Nicoud, Melisa Beatriz, Massari, Noelia A., Táquez Delgado, Mónica Alejandra, Herrero Ducloux, María V., Cremaschi, Graciela A., Medina, Vanina Araceli
Format: Artículo biblioteca
Language:spa
Published: Springer 2019
Subjects:CANCER DE MAMA, HISTAMINA, INMUNOLOGIA, GENES, BIOLOGIA CELULAR,
Online Access:https://repositorio.uca.edu.ar/handle/123456789/8620
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:ucacris:123456789-8620
record_format koha
spelling oai:ucacris:123456789-86202020-10-21T13:33:29Z Immunomodulatory role of histamine H4 receptor in breast cancer Sterle, Helena A. Nicoud, Melisa Beatriz Massari, Noelia A. Táquez Delgado, Mónica Alejandra Herrero Ducloux, María V. Cremaschi, Graciela A. Medina, Vanina Araceli CANCER DE MAMA HISTAMINA INMUNOLOGIA GENES BIOLOGIA CELULAR BACKGROUND: Although the role of histamine H4 receptor (H4R) in immune cells is being extensively investigated, its immunomodulatory function in cancer is completely unknown. This study aimed to investigate the role of H4R in antitumour immunity in a model of triple-negative breast cancer. METHODS: We evaluated growth parameters, histological characteristics and the composition of tumour, splenic and tumour draining lymph node (TDLN) immune subsets, in a syngeneic model, developed orthotopically with 4T1 cells in H4R knockout (H4R-KO) and wild-type mice. RESULTS: Mice lacking H4R show reduced tumour size and weight, decreased number of lung metastases and percentage of CD4+ tumour-infiltrating T cells, while exhibiting increased infiltration of NK cells and CD19+ lymphocytes. Likewise, TDLN of H4R-KO mice show decreased CD4+ T cells and T regulatory cells (CD4+CD25+FoxP3+), and increased percentages of NK cells. Finally, H4R-deficient mice show decreased Tregs in spleens and non-draining lymph nodes, and a negative correlation between tumour weight and the percentages of CD4+, CD19+ and NK splenic cells, suggesting that H4R also regulates antitumour immunity at a systemic level. CONCLUSIONS: This is the first report that demonstrates the participation of H4R in antitumour immunity, suggesting that H4R could be a target for cancer treatment. 2019-08-22T17:28:19Z 2019-08-22T17:28:19Z 2019 Artículo Sterle HA, Nicoud MB, Massari NA, et al. Immunomodulatory role of histamine H4 receptor in breast cancer [en linea]. British Journal of Cancer 2019;120(1):128-138. doi:10.1038/s41416-018-0173-z Registro en: https://repositorio.uca.edu.ar/handle/123456789/8620 0007-0920 (print) 1532-1827 (online) https://repositorio.uca.edu.ar/handle/123456789/8620 10.1038/s41416-018-0173-z 29988113 spa Acceso Abierto. 6 meses de embargo http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf Springer British Journal of Cancer 2019;120(1):128-138
institution UCA
collection DSpace
country Argentina
countrycode AR
component Bibliográfico
access En linea
databasecode dig-uca
tag biblioteca
region America del Sur
libraryname Sistema de bibliotecas de la UCA
language spa
topic CANCER DE MAMA
HISTAMINA
INMUNOLOGIA
GENES
BIOLOGIA CELULAR
CANCER DE MAMA
HISTAMINA
INMUNOLOGIA
GENES
BIOLOGIA CELULAR
spellingShingle CANCER DE MAMA
HISTAMINA
INMUNOLOGIA
GENES
BIOLOGIA CELULAR
CANCER DE MAMA
HISTAMINA
INMUNOLOGIA
GENES
BIOLOGIA CELULAR
Sterle, Helena A.
Nicoud, Melisa Beatriz
Massari, Noelia A.
Táquez Delgado, Mónica Alejandra
Herrero Ducloux, María V.
Cremaschi, Graciela A.
Medina, Vanina Araceli
Immunomodulatory role of histamine H4 receptor in breast cancer
description BACKGROUND: Although the role of histamine H4 receptor (H4R) in immune cells is being extensively investigated, its immunomodulatory function in cancer is completely unknown. This study aimed to investigate the role of H4R in antitumour immunity in a model of triple-negative breast cancer. METHODS: We evaluated growth parameters, histological characteristics and the composition of tumour, splenic and tumour draining lymph node (TDLN) immune subsets, in a syngeneic model, developed orthotopically with 4T1 cells in H4R knockout (H4R-KO) and wild-type mice. RESULTS: Mice lacking H4R show reduced tumour size and weight, decreased number of lung metastases and percentage of CD4+ tumour-infiltrating T cells, while exhibiting increased infiltration of NK cells and CD19+ lymphocytes. Likewise, TDLN of H4R-KO mice show decreased CD4+ T cells and T regulatory cells (CD4+CD25+FoxP3+), and increased percentages of NK cells. Finally, H4R-deficient mice show decreased Tregs in spleens and non-draining lymph nodes, and a negative correlation between tumour weight and the percentages of CD4+, CD19+ and NK splenic cells, suggesting that H4R also regulates antitumour immunity at a systemic level. CONCLUSIONS: This is the first report that demonstrates the participation of H4R in antitumour immunity, suggesting that H4R could be a target for cancer treatment.
format Artículo
topic_facet CANCER DE MAMA
HISTAMINA
INMUNOLOGIA
GENES
BIOLOGIA CELULAR
author Sterle, Helena A.
Nicoud, Melisa Beatriz
Massari, Noelia A.
Táquez Delgado, Mónica Alejandra
Herrero Ducloux, María V.
Cremaschi, Graciela A.
Medina, Vanina Araceli
author_facet Sterle, Helena A.
Nicoud, Melisa Beatriz
Massari, Noelia A.
Táquez Delgado, Mónica Alejandra
Herrero Ducloux, María V.
Cremaschi, Graciela A.
Medina, Vanina Araceli
author_sort Sterle, Helena A.
title Immunomodulatory role of histamine H4 receptor in breast cancer
title_short Immunomodulatory role of histamine H4 receptor in breast cancer
title_full Immunomodulatory role of histamine H4 receptor in breast cancer
title_fullStr Immunomodulatory role of histamine H4 receptor in breast cancer
title_full_unstemmed Immunomodulatory role of histamine H4 receptor in breast cancer
title_sort immunomodulatory role of histamine h4 receptor in breast cancer
publisher Springer
publishDate 2019
url https://repositorio.uca.edu.ar/handle/123456789/8620
work_keys_str_mv AT sterlehelenaa immunomodulatoryroleofhistamineh4receptorinbreastcancer
AT nicoudmelisabeatriz immunomodulatoryroleofhistamineh4receptorinbreastcancer
AT massarinoeliaa immunomodulatoryroleofhistamineh4receptorinbreastcancer
AT taquezdelgadomonicaalejandra immunomodulatoryroleofhistamineh4receptorinbreastcancer
AT herreroduclouxmariav immunomodulatoryroleofhistamineh4receptorinbreastcancer
AT cremaschigracielaa immunomodulatoryroleofhistamineh4receptorinbreastcancer
AT medinavaninaaraceli immunomodulatoryroleofhistamineh4receptorinbreastcancer
_version_ 1756275828985954304